OVID Ovid Therapeutics Inc far exceeds Q4 2025 EPS expectations shares rise nearly four percent Carlyle CG Stock Cash Secured Put 170 20260415 Albany Intl AIN Operational Review Q4 2025 EPS Misses Estimates